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Abstract 
BACKGROUND: Improving the effectiveness of rehabilitation of patients with osteoarthritis necessitates the use 
of drug electrophoresis with sinusoidal modulated currents (SMC-electrophoresis) in conjunction with drug 
therapy. The phytocomplex is proposed for electrophoresis composed of the compared, alfalfa and hops dry 
extract, containing flavonoids, coumestans, polysaccharides, steroids, essential amino acids, vitamins, mineral 
components and causing its possible use in osteoarthritis. 
AIM: The research aims to study the effect of the phytocomplex SMC-electrophoresis on the clinical symptoms 
and quality of life of patients with the knee joint osteoarthritis. 
METHODS: One hundred and eight patients were randomly distributed into 3 groups (n = 36). The phytocomplex 
SMC-electrophoresis was assigned to the first group, the amplipulse therapy (SMC) – to the second group, and 
the "basic" drug therapy – to the third group. The drug therapy of the patients of the third group was comparable 
with the drug treatment of those in the first two groups. The concentration of phytocomplex in the working solution 
was 10%. The electrotherapy was carried out in the aligned SMC mode in the first and fourth kind of works. 
Comparative indicators were as follows: WOMAC index, pain level on a visual analogue scale (VAS), Lequesne 
index, joint range of motion (JROM), articular and tendon indices, quality of life as per Health Assessment 
Questionnaire (HAQ). 
RESULTS: The use of the phytocomplex SMC-electrophoresis had a more pronounced positive effect on pain, 
knee joint function and quality of life of the patients compared with the treatment with drugs alone or using 
amplitude therapy. This was especially pronounced immediately after the rehabilitation. The analgesic effect was 
consistently maintained in the patients of the first group for up to 6 – 12 months, the second group – up to 3 – 6 
months in terms of the level of pain according to the WOMAC and Lequesne indices, VAS, articular and tendon 
indices. Stable results have been obtained for improving the functions of the knee joint for up to 6 – 12 months 
using the phytocomplex SMC-electrophoresis as per the WOMAC and Lequesne indices. In the treatment by the 
phytocomplex SMC-electrophoresis, no side effects were registered. 
CONCLUSION: The obtained results give grounds for further research on the evaluation of the effectiveness of 
using the phytocomplex SMC-electrophoresis in microcirculatory disorders in the affected joint, for correcting 
connective tissue metabolism and electrolyte metabolism in the patients with the knee joint osteoarthritis. 
 
 
 
Introduction 
 
An osteoarthritis is a heterogeneous group of 
diseases of various etiologies. The basis of 
osteoarthritis is the damage of all joint components, 
primarily of cartilage and subchondral bone, synovial 
membrane, ligaments, and periarticular muscle 
capsules [1]. The disease has a significant and 
widespread prevalence in the world [2], [3], [4]. It 
results from the interaction of multiple genetic and 
environmental factors, affects mostly people of the 
older age group, is characterized by a long course 
with the tendency to recrudescence and progression, 
deterioration in the quality of life of the patients, and 
disability [5], [6], [7], [8]. This determines the high 
social and economic significance of the disease [9], 
[10]. 
Traditionally, the treatment of osteoarthritis is 
comprehensive and includes medical and nonmedical 
methods, including the physiotherapeutic ones [11], 
[12], [13]. The low-frequency electrotherapy with 
SMC, or the amplitude therapy, in osteoarthritis has 
analgesic, neurostimulation, vasodilator, and 
trophostimulating effects [14]. To enhance the 
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therapeutic effect, amplipulse therapy is combined 
with the administration of drugs (SMC-
electrophoresis) [15], [16], [17], [18]. 
The phytocomplex for SMC-electrophoresis 
offered by the authors is a dry extract from grass and 
roots of bog strawberry, the alfalfa grass and stems or 
strobiles of common hop (TU 9375-021-00003938-11 
"Bog strawberry, alfalfa and hops dry extract 
(phytocomplex)") [19]. It contains a set of biologically 
active substances, including flavonoids, contestants, 
polysaccharides, steroids, essential oils, tannins, 
hydroxycinnamic and phenol carboxylic acids, 
essential amino acids, vitamins, and mineral 
components, which stipulates its possible use in 
medicine for inflammatory-degenerative diseases of 
the locomotor system, including osteoarthritis. 
The scope of the work was to study the effect 
of the phytocomplex SMC-electrophoresis on the 
clinical symptoms and quality of life of the patients 
with the knee joint osteoarthritis. 
 
 
Material and Methods 
 
The study included 108 patients with a 
verified diagnosis of the knee joint osteoarthritis. 
Clinical trials were carried out by the ethical principles 
of the Helsinki Declaration, good clinical practice 
(GCP), and applicable regulatory requirements. The 
clinical trials of the phytocomplex SMC-
electrophoresis in the rehabilitation of patients with the 
knee osteoarthritis were allowed by the Interuniversity 
Ethics Committee under the Association of Medical 
and Pharmacy Universities of Russia. 
The criteria for inclusion of patients in the 
study were a verified diagnosis of the knee joint 
osteoarthritis according to the criteria of the American 
College of Rheumatology (ACR), 1-2 Kellgren-
Lawrence grade X-ray stage, without synovitis or with 
its small manifestations, the intensity of pain in the 
affected joint on VAS − not less than 40 mm, the 
administration of Symptomatic Slow Acting Drugs for 
Osteoarthritis (SYSADOA) as per generally accepted 
regimens in a stable dosage − at least 3 months 
before the start of the study, with the possibility of 
administration of nonsteroidal anti-inflammatory drugs 
(NSAIDs) in stable, standard daily doses, and the 
written consent to participate in the test. The exclusion 
criteria were as follows: secondary knee joint 
osteoarthritis, intra-articular administration of any 
drugs within 6 weeks prior to the study, treatment with 
glucocorticoids during the last month, history of 
operation on the knee joint tested, pronounced 
symptoms of synovitis, pregnancy, breastfeeding, 
contraindications to the use of SMC, individual 
intolerance to the biologically active substances of the 
phytocomplex, the presence of other rheumatic 
diseases, the body mass index above 40 kg/m
2
, and 
the presence of severe comorbidities. 
Among the patients included in the study, 
73.1% (79 people) were females, and 26.9% (29 
people) were males. The ratio of men and women was 
approximately 1:3. The age range of the surveyed 
people ranged from 40 to 78 years. Me (sample 
median) and IQR (interquartile range, 25th and 75th 
percentile) of the patients' age, disease duration and 
body mass index at the time of the survey were 54.4 
(50.0 and 61.5) years, 5.3 (3.0 and 7.5) years, and 
30.5 (25.6 and 34.7) kg/m2, respectively. The first X-
ray stage of the knee joint osteoarthritis was observed 
in 35.2% of the patients, the second stage – in 64.8%. 
In the majority of the patients (81%), the pathological 
process was one-sided, and only in 19%, it was two-
sided one. A rapidly progressive course of the disease 
was observed in 3.7 % of the patients. A number of 
the patients included in the study were diagnosed with 
comorbidities, including hypertension (37 people), 
diabetes (12 people), and metabolic syndrome (4 
people), which were combined in some patients.  
All patients with knee osteoarthritis included in 
the study, along with general clinical examination 
methods, used special research methods.  
The clinical condition of the patients with 
osteoarthritis was assessed by examining the knee 
joints and quantifying indicators of clinical symptoms.  
The range of motion in the affected joint 
(Mollier flexion) was evaluated using a Goniometer 
(ISOM 360°, 6′′, Baseline, USA). The principle of D.M. 
Ritchie et al. were taken as the basis of the articular 
and tendon indices [20]. The level of pain was 
determined with moderate pressure of about 4 kg/cm
2
 
(before whitening the nail of the main phalanx) on the 
joint (along with with the joint space) and the place of 
attachment of tendons and ligaments. The 4-point 
scale was used as follows: 0 – no pain, 1 – patient 
states pain, 2 – patient states pain and frowns, 3 – 
patient withdraws limb. The duration of morning 
stiffness was estimated in minutes. 
For more detailed clinical characteristics of 
the patients, the parameters recommended by the 
Osteoarthritis Research Society International (OARSI) 
were used, namely: the pain level indicator as per 
VAS (at rest and in motion); WOMAC index (Western 
Ontario and McMaster Universities Osteoarthritis 
Index): pain index (PW), stiffness index (SW), daily 
activity rate (FW); and Lequesne Index.  
The quality of life of the patients with knee 
osteoarthritis was assessed by HAQ. 
The frequency and nature of adverse events, 
the dynamics of the pulse, blood pressure, 
electrocardiography (ECG) were used as safety 
parameters. 
All patients were randomly (by random 
numbers generated using a computer program) 
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divided into 3 groups, comparable in clinical and 
functional characteristics. Patients of the first group 
(36 people) were on rehabilitation, including the 
phytocomplex SMC-electrophoresis. The amplitude 
therapy was prescribed to the patients of the second 
group (36 people) according to the similar procedure 
with the first group, without the phytocomplex. The 
observed patients of the first two groups continued to 
receive drug therapy, which did not change during the 
physiotherapy course. Patients of the third group (36 
people) received only drug treatment: SYSADOA 
basic – 36 people (100%), NSAIDs – 8 people 
(22.2%), general tonic agents, and vitamin 
preparations. The drug therapy of the patients of the 
third group was comparable with the drug treatment of 
the patients in the first two groups.  
The electrotherapy was performed on the 
knee joint region using a transverse technique in a 
straightened SMC mode with the first and fourth type 
of work, 5 min each. The modulation frequency was 
equal to 100 Hz, the modulation depth – to 75%, the 
half-periods’ duration was 2 and 3 sec, the current 
strength – 5 mA, and the duration of exposure – 10 
min, with 10 daily procedures per course. The 
procedures were performed on an Amplipulse-6 
apparatus (Elektroapparat, Russia). 
A working solution of the electrophoresis 
phytocomplex was prepared ex tempore by dissolving 
the dry extract (10 parts) in dimethyl sulfoxide (15 
parts) and then adding warm (40°C) distilled water (up 
to 100 parts). 20 ml of the working solution was 
applied to pads, which were placed on the medial and 
lateral surfaces of the affected knee joint. The content 
of flavonoids in the working solution was 0.7% (in 
terms of quercetin – the predominant flavonoid of the 
phytocomplex) or 4% (in terms of the absolute dry 
residue of flavonoids). The phytocomplex 
concentration in the working solution was chosen 
experimentally as a result of the study of transdermal 
delivery of the phytocomplex biologically active 
substances under the SMC action in model 
experiments [21]. It had been previously found that 
SMC electrophoresis did not destroy the main active 
substances of the phytocomplex, introduced from two 
poles.  
The results were statistically processed using 
the SPSS.Statistics.v17.Multilingual-EQUiNOX (SPSS 
Inc) software. 
 
 
Results 
 
The main clinical symptoms in the examined 
patients are presented in Figure 1. Central to the 
clinical picture was the pain in the joint (100 %), both 
in the patients with the first and the second disease 
stage. The overwhelming majority of the patients with 
the second stage osteoarthritis also had morning 
stiffness (98 %), limited movement in the joint (79 %), 
and a crunch in the joint (66 %). It should be noted 
that all clinical symptoms occurred approximately two 
times more often in the patients with the second stage 
of the disease than with the first one and were more 
pronounced. 
 
Figure 1: The main complaints of the patients with knee 
osteoarthritis included in the study 
 
The clinical condition of the patients with the 
knee joint osteoarthritis was assessed by the JROM, 
the duration of morning stiffness (MS), the articular 
(AI) and the tendon (TI) indexes (Table 1). The use of 
the method of the phytocomplex SMC-electrophoresis 
(first group) had a beneficial and significant effect on 
these parameters in the patients with the knee 
osteoarthritis. Thus, the MS index decreased 2.5 
times, palpation pain decreased by 60% (AI) and 55% 
(TI), and the JROM increased by almost 14%.  
A comparative analysis of the investigated 
rehabilitation methods showed that the phytocomplex 
SMC-electrophoresis method (first group) was more 
effective than drug therapy (third group) immediately 
after the physiotherapy and 3 – 6 months after that 
according to the values of MS, CI and TI (P < 0.05). 
When analysing two physiotherapeutic rehabilitation 
methods, it has been established that immediately 
after the physiotherapy, the phytocomplex SMC-
electrophoresis (first group) was significantly better 
than the amplipulse therapy (second group) in terms 
of AI and TI (P < 0.05). The effect persisted for up to 3 
months after the course of treatment in terms of TI (P 
= 0.044). In terms of MS, the phytocomplex SMC-
electrophoresis method (first group) was better than 
the effects of SMC (second group) 3 months after the 
physiotherapy (P = 0.020). The effect persisted for up 
to 6 months (P = 0.038). 
Pain in the joint is one of the most important 
clinical signs of osteoarthritis. Therefore, the pain 
level, as per VAS is the most significant indicator for 
assessing the effectiveness of patient rehabilitation. It 
was found that the studied physiotherapy 
rehabilitation methods had reliably reduced the VAS 
indicators by the end of the treatment by 59% (at rest) 
and 51% (in motion) using the phytocomplex SMC-
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electrophoresis (first group), 54% (at rest) and 43% (in 
motion) for the amplitude therapy (second group) 
(Figure 2). 
Table 1: The results of the comparative analysis of the 
effectiveness of various methods of rehabilitation of the 
patients with the knee osteoarthritis in terms of JROM, MS, AI 
and TI 
Examination 
period 
 
Group 
Indicator, M ± σ* 
JROM, 
degree 
MS, minute AI, points TI, points 
 
 
Before treatment 
1 (n = 36) 116.5 ± 19.2 18.2 ± 3.6 1.84 ± 0.36 1.34 ± 0.26 
2 (n = 36) 121.5 ± 9.6 15.6 ± 4.0 1.73 ± 0.34 1.37 ± 0.30 
3 (n = 36) 124.6 ± 16.8 17.1 ± 3.4 1.79 ± 0.40 1.26 ± 0.22 
 
R. 
Р
1-2
 = Ur Р
1
 = 
Ur 
Р
1-3
 = Ur Р
2
 = 
Ur 
Р
2-3
 = Ur Р
3
 = 
Ur 
Р
1-2
 = Ur Р
1
 
= Ur 
Р
1-3
 = Ur Р
2
 
= Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
Р
1-2
 = Ur Р
1
 
= Ur 
Р
1-3
 = Ur Р
2
 
= Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
Р
1-2
 = Ur Р
1
 
= Ur 
Р
1-3
 = Ur Р
2
 
= Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
 
 
 
After treatment 
1 (n = 36) 132.3 ± 25.6 7.3 ± 1.8 0.74 ± 0.30 0,60 ± 0,18 
2 (n = 36) 126.6 ± 19.8 7.0 ± 2.4 0.93 ± 0.42 0,79 ± 0,15 
3 (n = 36) 125.2 ± 23.6 16.1 ± 3.4 1.68 ± 0.72 1.30 ± 0.32 
 
Р 
Р
1-2
 = Ur Р
1
 = 
0.046 
Р
1-3
 = 0.049 
Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 = 
Ur 
Р
1-2
 = Ur Р
1
 
= 0.001 
Р
1-3
 = 0.001 
Р
2
 = 0.001 
Р
2-3
 = 0.001 
Р
3
 = Ur 
Р
1-2
 = 0.040 
Р
1
 = 0.001 
Р
1-3
 = 0.001 
Р
2
 = 0.002 
Р
2-3
 = 0.003 
Р
3
 = Ur 
Р
1-2
 = 0,041 
Р
1
 = 0,001 
Р
1-3
 = 0,001 
Р
2
 = 0,001 
Р
2-3
 = 0,001 
Р
3
 = Ur 
 
3 months after 
treatment 
1 (n = 36) 124.2 ± 24.6 8.7 ± 2.4 0.96 ± 0.42 0.91 ± 0.30 
2 (n = 36) 127.9 ± 26.4 11.4 ± 3.0 1.15 ± 0.48 0.97 ± 0.18 
3 (n = 36) 126.7 ± 33.2 16.8 ± 3.2 1.73 ± 0.54 1.22 ± 0.26 
 
Р 
Р
1-2
 = Ur Р
1
 = 
Ur 
Р
1-3
 = Ur Р
2
 = 
Ur 
Р
2-3
 = Ur Р
3
 = 
Ur 
Р
1-2
 = 0.020 
Р
1
 = 0.001 
Р
1-3
 = 0.001 
Р
2
 = 0.020 
Р
2-3
 = 0.020 
Р
3
 = Ur 
Р
1-2
 = 0.044 
Р
1
 = 0.002 
Р
1-3
 = 0.002 
Р
2
 = 0.005 
Р
2-3
 = 0.010 
Р
3
 = Ur 
Р
1-2
 = Ur Р
1
 
= 0.011 
Р
1-3
 = 0.010 
Р
2
 = 0.020 
Р
2-3
 = 0.016 
Р
3
 = Ur 
 
6 months after 
treatment 
1 (n = 36) 120.8 ± 22.4 12.2 ± 4.2 1.44 ± 0.48 1.15 ± 0.24 
2 (n = 36) 125.0 ± 31.2 14.2 ± 3.0 1.51 ± 0.48 1.34 ± 0.14 
3 (n = 36) 127.2 ± 28.0 17.6 ± 4.0 1.75 ± 0.60 1.25 ± 0.22 
 
Р 
Р
1-2
 = Ur Р
1
 = 
Ur 
Р
1-3
 = Ur Р
2
 = 
Ur 
Р
2-3
 = Ur Р
3
 = 
Ur 
Р
1-2
 = 0.038 
Р
1
 = 0.005 
Р
1-3
 = 0.001 
Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
Р
1-2
 = Ur Р
1
 
= 0.030 
Р
1-3
 = 0.030 
Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
Р
1-2
 = Ur Р
1
 
= 0.042 
Р
1-3
 = 0.042 
Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
 
12 months after 
treatment 
1 (n = 36) 118.2 ± 27.2 14.9 ± 3.2 1.62 ± 0.48 1.29 ± 0.26 
2 (n = 36) 124.1 ± 18.6 14.8 ± 3.8 1.66 ± 0.42 1.30 ± 0.28 
3 (n = 36) 126.1 ± 30.6 18.3 ± 4.4 1.78 0 ± .48 1.20 ± 0.34 
 
Р 
Р
1-2
 = Ur Р
1
 = 
Ur 
Р
1-3
 = Ur Р
2
 = 
Ur 
Р
2-3
 = Ur Р
3
 = 
Ur 
Р
1-2
 = Ur Р
1
 
= Ur 
Р
1-3
 = Ur Р
2
 
= Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
Р
1-2
 = Ur Р
1
 
= Ur 
Р
1-3
 = Ur Р
2
 
= Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
Р
1-2
 = Ur Р
1
 
= Ur 
Р
1-3
 = Ur Р
2
 
= Ur 
Р
2-3
 = Ur Р
3
 
= Ur 
* The experimental, empirical distribution of JROM, MS, AI, TI variables did not differ much 
from the normal distribution (the Kolmogorov-Smirnov criterion and the schedule of the 
normal distribution in SPSS); ** The significance of differences between the groups and in 
the group before and after treatment as per the Student's t-test (numbers indicate the 
numbers of the groups); Ur is the unreliable. 
 
The phytocomplex electrophoresis method 
(first group) immediately after the physiotherapy 
course was not significantly better than the amplipulse 
therapy method (second group) (P > 0.05). When 
assessing the analgesic action stability after 3 – 12 
months, it was assumed that the effect had been 
stable at the pain level as per VAS of no more than 40 
mm. Three months after the rehabilitation, the VAS 
indicators in the first group of the patients were at a 
level of less than 40 mm. In the subsequent periods, 
the analgesic effect persisted and was significantly 
better than the pain level indicators in the patients of 
the second and third groups (P < 0.05). When 
exposed to SMC (second group), the analgesic effect 
persisted for up to 6 months after the physiotherapy; 
at subsequent follow-up periods, the VAS indicators 
did not significantly differ from the pain level data in 
the patients of the third group who had received only 
drug treatment (P > 0.05). The proportion of the 
patients with VAS ≤ 40 mm during the rehabilitation by 
the phytocomplex SMC-electrophoresis (first group) 
after 3 months decreased slightly and amounted to 
54%. When using the amplipulse therapy (second 
group), the proportion of the patients with VAS ≤ 40 
mm decreased to 34% 3 months after the 
physiotherapy, and in the subsequent periods, these 
figures did not differ from those in the third group. 
 
Figure 2: The results of the comparative analysis of the 
effectiveness of various methods of rehabilitation of the patients 
with the knee osteoarthritis in terms of pain level as per VAS (in 
movement). The significance of differences between the groups (*) 
and in the group (**) before and after treatment as per the Student’s 
t-test (group numbers are indicated in numbers) 
 
The WOMAC index can also be used for a 
comparative evaluation of the effectiveness of various 
rehabilitation methods for patients with osteoarthritis. 
The significant decrease in the PW, SW and FW 
indicators of the WOMAC index was observed by the 
end of the physiotherapy course using the 
phytocomplex SMC-electrophoresis (first group) by 
40%, and by the end of the amplipulse therapy 
(second group) – by 30% (Table 2). 
Table 2: The results of the comparative analysis of the 
effectiveness of various methods of rehabilitation of the 
patients with the knee osteoarthritis as per the WOMAC index 
Examination period Group WOMAC index, score, M ± σ* 
PW SW FW 
 
 
Before treatment 
First (n = 36) 34.3 ± 5.6 13.7 ± 2.4 116.1 ± 20.4 
Second (n = 36) 33.3 ± 6.8 13.2 ± 2.7 112.5 ± 22.6 
Third (n = 36) 31.9 ± 6.2 12.8 ± 2.0 108.5 ± 20.3 
 
Р** 
Р
1-2 
= Ur Р
1 
= Ur 
Р
1-3
 = Ur Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 = Ur 
Р
1-2 
= Ur Р
1 
= Ur 
Р
1-3
 = Ur Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 = Ur 
Р
1-2 
= Ur Р
1 
= Ur 
Р
1-3
 = Ur Р
2
 = Ur 
Р
2-3
 = Ur Р
3
 = Ur 
 
 
After treatment 
First (n = 36) 20.6 ± 4.2 8.2 ± 1.6 69.9 ± 14.0 
Second (n = 36) 24.6 ± 4.0 9.8 ± 2.4 83.1 ± 18.6 
Third (n = 36) 30.6 ± 6.4 12.3 ± 3.0 103.9 ± 20.4 
 
Р 
Р
1-2
 = 0.043 Р
1
 = 
0.001 
Р
1-3
 = 0.001 Р
2
 = 
0.013 
Р
2-3
 = 0.027 Р
3
 = 
Ur 
Р
1-2
 = 0.040 Р
1
 = 
0.001 
Р
1-3
 = 0.001 Р
2
 = 
0.009 
Р
2-3
 = 0.025 Р
3
 = 
Ur 
Р
1-2
 = 0.038 Р
1
 = 
0.002 
Р
1-3
 = 0.002 Р
2
 = 
0.011 
Р
2-3
 = 0.016 Р
3
 = 
Ur 
 
 
3 months after treatment 
First (n = 36) 23.2 ± 4.6 9.3 ± 1.8 78.6 ± 16.0 
Second (n = 36) 27.2 ± 5.2 10.8 ± 2.2 91.8 ± 21.4 
Third (n = 36) 31.4 ± 6.8 12.5 ± 2.8 106.6 ± 22.0 
 
Р 
Р
1-2
 = 0.041 Р
1
 = 
0.005 
Р
1-3
 = 0.012 Р
2
 = 
0.033 
Р
2-3
 = 0.040 Р
3
 = 
Ur 
Р
1-2
 = 0.037 Р
1
 = 
0.003 
Р
1-3
 = 0.030 Р
2
 = 
0.028 
Р
2-3
 = 0.040 Р
3
 = 
Ur 
Р
1-2
 = 0.043 Р
1
 = 
0.005 
Р
1-3
 = 0.035 Р
2
 = 
0.038 
Р
2-3
 = 0.040 Р
3
 = 
Ur 
 
 
6 months after treatment 
First (n = 36) 24.6 ± 5.0 9.7 ± 2.8 83.6 ± 16.0 
Second (n = 36) 28.1 ± 6.2 11.2 ± 2.2 95.7 ± 20.4 
Third (n = 36) 29.8 ± 7.1 12.0 ± 2.4 103.9 ± 21.6 
 
Р 
Р
1-2
 = 0.040 Р
1
 = 
0.010 
Р
1-3
 = 0.034 Р
2
 = 
0.037 
Р
2-3
 = Ur Р
3
 = Ur 
Р
1-2
 = 0.042 Р
1
 = 
0.015 
Р
1-3
 = 0.038 Р
2
 = 
0.040 
Р
2-3
 = Ur Р
3
 = Ur 
Р
1-2
 = 0.040 Р
1
 = 
0.010 
Р
1-3
 = 0.033 Р
2
 = 
0.040 
Р
2-3
 = Ur Р
3
 = Ur 
 
 
12 months after treatment 
First (n = 36) 27.2 ± 5.8 11.1 ± 2.8 94.3 ± 19.0 
Second (n = 36) 31.0 ± 7.0 12.6 ± 2.5 106.9 ± 23.2 
Third (n = 36) 31.3 ± 6.2 12.5 ± 2.4 107.0 ± 22.8 
 
Р 
P
1-2
 = 0.044 P
1
 = 
0.030 
P
1-3
 = 0.030 P
2
 = 
Ur 
Р
2-3 
= Ur Р
3 
= Ur 
Р
1-2
 = 0.042 Р
1
 = 
0.036 
Р
1-3
 = 0.040 Р
2
 = 
Ur 
Р
2-3
 = Ur Р
3
 = Ur 
Р
1-2
 = 0.040 Р
1
 = 
0.037 
Р
1-3
 = 0.040 Р
2
 = 
Ur 
Р
2-3
 = Ur Р
3
 = Ur 
* The experimental, empirical distribution of WOMAC variables did not differ much from the normal 
distribution (the Kolmogorov-Smirnov criterion and the schedule of the normal distribution in SPSS); ** The 
significance of differences between the groups and in the group before and after treatment as per the 
Student's t-test (numbers indicate the numbers of the groups). 
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A comparative analysis of various methods of 
treating knee osteoarthritis has shown that when 
using the phytocomplex SMC-electrophoresis (first 
group) immediately after the rehabilitation, the 
WOMAC indicators were significantly better than with 
the amplipulse therapy (second group) (P < 0.05) and 
with drug treatment (third group) (P < 0.05). This 
picture persisted for 3 – 12 months after the 
rehabilitation. The WOMAC indices, when exposed to 
SMC (second group) 6 months after the course of 
treatment did not significantly differ from the drug 
treatment data (third group) (P > 0.05). 
The study of the dynamics of the Lequesne 
index in the 3 research groups has shown that the 
largest decrease in this indicator was observed in the 
first group after using the phytocomplex SMC-
electrophoresis (45%) (Figure 3). This method of 
rehabilitation of the patients with knee osteoarthritis 
was significantly better by the Lequesne index 
compared with the amplitude therapy (second group) 
and drug treatment (third group) immediately after the 
physiotherapy and 6 months after (P < 0.05). The 
arithmetic means values of the Lequesne index 12 
months after the rehabilitation were in the range of 10 
– 11 points and did not differ significantly in all 
research groups (P > 0.05). 
 
Figure 3: The results of the comparative analysis of the 
effectiveness of various methods of rehabilitation of the patients 
with the knee osteoarthritis as per the Lequesne index. The 
significance of differences between the groups (*) and in the group 
(**) before and after treatment as per the Student’s t-test (group 
numbers are indicated in numbers) 
 
The quality of life of the patients with knee 
osteoarthritis was assessed using the HAQ index. A 
significant decrease in HAQ indices was observed 
immediately after the rehabilitation using the 
phytocomplex SMC-electrophoresis (first group − by 
34%; P = 0.003) and the amplitude therapy (second 
group − by 28%, P = 0.015) (Figure 4). These 
indicators were significantly better than those of HAQ 
obtained using only the drug therapy (third group) (P < 
0.05). After 3 – 12 months of observation, the HAQ 
values in the first and second groups did not differ 
significantly (P > 0.05). HAQ parameters ≤ 20 points 
were taken as satisfactory (the functional state of the 
joint was not impaired). In the groups under study, the 
predominant proportion of HAQ parameters before the 
treatment was lower than 20. Therefore, the HAQ 
values after the rehabilitation and 3 – 12 months after 
were satisfactory.  
Currently, there are no systematic works on 
the effect of flavonoids on the clinical symptoms and 
quality of life of patients with osteoarthritis during 
electrophoresis. The only reliable results concern the 
relief of clinical manifestations of osteoarthritis of the 
knee joint according to the WOMAC index (in 64% of 
cases) when using dexamethasone sodium 
phosphate electrophoresis [17], pain relief (according 
to VAS) and the functional disability index decrease 
immediately after treatment and for the next six weeks 
when using sodium salicylate electrophoresis [16], 
increasing the effectiveness of degenerative 
osteoarthropathy treatment (by 19%) when using 
electrophoresis of a Chinese drug compared to 
electric current monotherapy [18], which is consistent 
with the results of our research. 
 
Figure 4: The results of the comparative analysis of the 
effectiveness of various methods of rehabilitation of the patients 
with the knee osteoarthritis as per the HAQ index. The significance 
of differences between the groups (*) and in the group (**) before 
and after treatment as per the Student’s t-test (group numbers are 
indicated in numbers) 
 
 
Discussion 
 
The study has shown that the use of the 
phytocomplex SMC-electrophoresis in conjunction 
with the drug therapy has a more pronounced effect 
on the clinical symptoms of the patients with the knee 
joint osteoarthritis compared with the drug therapy or 
shared use of drugs with the amplipulse therapy. This 
was especially pronounced immediately after the 
rehabilitation. The analgesic effect was consistently 
maintained using the phytocomplex SMC-
electrophoresis for 6 – 12 months, with the amplitude 
therapy for 3 – 6 months in terms of the pain 
syndrome (PW) of the WOMAC index, as well as 
VAS, Lequesne index, articular and tendon indices. 
Stable results have been obtained in improving the 
functions of the knee joint during the rehabilitation 
using the phytocomplex SMC-electrophoresis in terms 
of stiffness (SW) and daily activity (FW) of the 
WOMAC index. It should be noted that when using the 
phytocomplex SMC-electrophoresis, no side effects 
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were recorded.  
The obtained results give grounds for further 
research on the assessment of the effectiveness of 
using the phytocomplex SMC-electrophoresis in 
microcirculatory disorders in the affected joint, to 
correct the connective tissue metabolism and 
electrolyte metabolism in the patients with the 
knee osteoarthritis. 
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